Koshinski Asset Management
IMGN

Koshinski Asset Management’s Immunogen Inc IMGN Stock Holding History

Koshinski Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,622
Closed -$7.72K – 2065
2022
Q1 		$7.72K Sell
1,622
-20
-1% -$111 ﹤0.01% 1680
2021
Q4 		$12.2K Buy
1,642
+26
+2% +$162 ﹤0.01% 1575
2021
Q3 		$9.16K Buy
+1,616
New +$9.34K ﹤0.01% 1685

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Koshinski Asset Management's IMGN Position: Q2 2022 in Review

Koshinski Asset Management sold out of Immunogen Inc (IMGN) in Q2 2022, closing a stake of 1,622 shares — an estimated $7.72K sold.

Koshinski Asset Management first reported a position in IMGN in Q3 2021 and held it in 3 quarters. The position peaked at $12.2K in Q4 2021. 216 funds tracked by Wall St. Rank hold IMGN as of Q2 2022.

  • Koshinski Asset Management reported no remaining Immunogen Inc position as of Q2 2022 after selling out during the quarter.
  • Koshinski Asset Management sold 1,622 Immunogen Inc shares in Q2 2022, an estimated $7.72K.
  • Koshinski Asset Management first reported a position in Immunogen Inc in Q3 2021 and held it in 3 quarters.
  • Koshinski Asset Management's Immunogen Inc position peaked at $12.2K in Q4 2021.
  • 216 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2022.

Based on Koshinski Asset Management's 13F filing for Q2 2022, filed 12 Jul 2022.